NEKTAR THERAPEUTICS — Director's Dealing 2021

Jan 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2020-12-30

Reporting Person: WHITFIELD ROY A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-30	Common Stock	G	51500	$0.00	Disposed	185850	Direct
2020-12-30	Common Stock	G	51500	$0.00	Acquired	51500	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	20000	Indirect

Footnotes

F1: This transaction involved a gift of shares by Mr. Whitfield to a trust for the benefit of Mr. Whitfield's family. Mr. Whitfield is the sole trustee of this trust.